News and Announcements
Fintech growing 30% MoM achieved USD$0 to $120M GMV and $0 to $576K revenue p/a in first 10 months of trading
- Published November 17, 2022 7:05AM UTC
- Publisher A Dizon
- Categories Company Updates
Lopay is a payment company focused on helping small and medium-sized businesses across the world accept in-person payments faster and more economically
Trusted by over 8,000 businesses in the United Kingdom, Lopay is the fastest and most economical way to take in-person payments. The company has already grown from USD $0 to $120m per year in processing volume since launching in January 2022.
- Backed by U.K’s leading financiers and business titans including CEO of $1T AUM Schroders Asset Management
- In the first 10 months of trading: USD $0 to $120m GMV and $0 to $576k revenue p/a
- >8,000 businesses acquired growing 30% month on month
- Going after the $4T in-person payments annually representing a $20B revenue p/a global opportunity
Connect with the company and learn more about Lopay by accessing their deal room here.
Company Updates
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
